Increased and Prolonged Pulmonary Fibrosis in Surfactant Protein C-Deficient Mice Following Intratracheal Bleomycin

Gross, 2001, Idiopathic pulmonary fibrosis, N Engl J Med, 345, 517, 10.1056/NEJMra003200 American Thoracic Society, 2000, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am J Respir Crit Care Med, 161, 646, 10.1164/ajrccm.161.2.ats3-00 Marshall, 1997, The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?, Int J Biochem Cell Biol, 29, 107, 10.1016/S1357-2725(96)00141-0 Marshall, 2000, Adult familial cryptogenic fibrosing alveolitis in the United Kingdom, Thorax, 55, 143, 10.1136/thorax.55.2.143 Bitterman, 1986, Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members, N Engl J Med, 314, 1343, 10.1056/NEJM198605223142103 Hodgson, 2002, Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland, Thorax, 57, 338, 10.1136/thorax.57.4.338 Nogee, 2001, A mutation in the surfactant protein C gene associated with familial interstitial lung disease, N Engl J Med, 344, 573, 10.1056/NEJM200102223440805 Amin, 2001, Surfactant protein deficiency in familial interstitial lung disease, J Pediatr, 139, 85, 10.1067/mpd.2001.114545 Nogee, 2002, Mutations in the surfactant protein C gene associated with interstitial lung disease, Chest, 121, 20S, 10.1378/chest.121.3_suppl.20S Thomas, 2002, Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred, Am J Respir Crit Care Med, 165, 1322, 10.1164/rccm.200112-123OC Weaver, 1998, Synthesis, processing and secretion of surfactant proteins B and C, Biochim Biophys Acta, 1408, 173, 10.1016/S0925-4439(98)00066-0 Beers, 2005, Surfactant protein C biosynthesis and its emerging role in conformational lung disease, Annu Rev Physiol, 67, 663, 10.1146/annurev.physiol.67.040403.101937 Lazo, 1990, Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis, Pharmacol Ther, 47, 347, 10.1016/0163-7258(90)90061-6 Bowden, 1984, Unraveling pulmonary fibrosis: the bleomycin model, Lab Invest, 50, 487 Phan, 1992, Lung cytokine production in bleomycin-induced pulmonary fibrosis, Exp Lung Res, 18, 29, 10.3109/01902149209020649 Zhang, 1994, Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study, Am J Pathol, 145, 114 Glasser, 2001, Altered stability of pulmonary surfactant in SP-C-deficient mice, Proc Natl Acad Sci USA, 98, 6366, 10.1073/pnas.101500298 Strutz, 1995, Identification and characterization of a fibroblast marker: FSP1, J Cell Biol, 130, 393, 10.1083/jcb.130.2.393 Lawson, 2005, Characterization of fibroblast-specific protein 1 in pulmonary fibrosis, Am J Respir Crit Care Med, 171, 899, 10.1164/rccm.200311-1535OC Hoff, 1999, Elastin gene expression is upregulated during pulmonary fibrosis, Connect Tissue Res, 40, 145, 10.3109/03008209909029110 Blackwell, 1999, Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats, Am J Respir Crit Care Med, 159, 1644, 10.1164/ajrccm.159.5.9806166 Pryhuber, 1991, Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity, Pediatr Res, 30, 597, 10.1203/00006450-199112000-00023 Akinbi, 1997, Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide, J Biol Chem, 272, 9640, 10.1074/jbc.272.15.9640 Noah, 2003, Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis, Am J Respir Crit Care Med, 168, 685, 10.1164/rccm.200301-005OC Okada, 1997, Early role of Fsp1 in epithelial-mesenchymal transformation, Am J Physiol, 273, F563 Okada, 1998, Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene, Am J Physiol, 275, F306 Iwano, 2001, Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts, Mol Ther, 3, 149, 10.1006/mthe.2000.0251 Iwano, 2002, Evidence that fibroblasts derive from epithelium during tissue fibrosis, J Clin Invest, 110, 341, 10.1172/JCI0215518 Weaver, 2001, Function of surfactant proteins B and C, Annu Rev Physiol, 63, 555, 10.1146/annurev.physiol.63.1.555 Glasser, 2003, Pneumonitis and emphysema in sp-C gene targeted mice, J Biol Chem, 278, 14291, 10.1074/jbc.M210909200 Ikegami, 2002, Deficiency of SP-B reveals protective role of SP-C during oxygen lung injury, J Appl Physiol, 92, 519, 10.1152/japplphysiol.00459.2001 Hawgood, 1996, Lung function in premature rabbits treated with recombinant human surfactant protein-C, Am J Respir Crit Care Med, 154, 484, 10.1164/ajrccm.154.2.8756826 Davis, 1998, Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant, Am J Respir Crit Care Med, 157, 553, 10.1164/ajrccm.157.2.97-08019 Hafner, 1998, Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury, Am J Respir Crit Care Med, 158, 270, 10.1164/ajrccm.158.1.9712061 Lewis, 1999, Dosing and delivery of a recombinant surfactant in lung-injured adult sheep, Am J Respir Crit Care Med, 159, 741, 10.1164/ajrccm.159.3.9806069 Spragg, 2000, Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury, J Appl Physiol, 88, 674, 10.1152/jappl.2000.88.2.674 Floros, 1998, Genetics of the hydrophilic surfactant proteins A and D, Biochim Biophys Acta, 1408, 312, 10.1016/S0925-4439(98)00077-5 Hay, 1991, Mechanisms of bleomycin-induced lung damage, Arch Toxicol, 65, 81, 10.1007/BF02034932 Savani, 2001, Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C, Am J Physiol, 281, L685 Schmidt, 2004, Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis, Toxicol Appl Pharmacol, 195, 218, 10.1016/j.taap.2003.11.011 Hagimoto, 1997, Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice, Am J Respir Cell Mol Biol, 16, 91, 10.1165/ajrcmb.16.1.8998084 Kuwano, 1999, Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis, J Clin Invest, 104, 13, 10.1172/JCI5628 Wang, 2000, Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor, Am J Physiol, 279, L143 Kuwano, 2001, Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor, Am J Physiol, 280, L316 Lee, 2004, Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis, J Exp Med, 200, 377, 10.1084/jem.20040104 Uhal, 1998, Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung, Am J Physiol, 275, L1192 Uhal, 2002, Apoptosis in lung fibrosis and repair, Chest, 122, 293S, 10.1378/chest.122.6_suppl.293S Kuwano, 1996, P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 154, 477, 10.1164/ajrccm.154.2.8756825 Selman, 2001, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy, Ann Intern Med, 134, 136, 10.7326/0003-4819-134-2-200101160-00015 Whitsett, 2002, Hydrophobic surfactant proteins in lung function and disease, N Engl J Med, 347, 2141, 10.1056/NEJMra022387 Nogee, 2002, Abnormal expression of surfactant protein C and lung disease, Am J Respir Cell Mol Biol, 26, 641, 10.1165/ajrcmb.26.6.f241 Beers, 1998, Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis, J Biol Chem, 273, 15287, 10.1074/jbc.273.24.15287 Keller, 1992, The C-terminal domain of the pulmonary surfactant protein C precursor contains signals for intracellular targeting, Am J Respir Cell Mol Biol, 6, 601, 10.1165/ajrcmb/6.6.601 Mulugeta, 2005, A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation, Am J Respir Cell Mol Biol, 32, 521, 10.1165/rcmb.2005-0009OC Bridges, 2003, Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice, J Biol Chem, 278, 52739, 10.1074/jbc.M309599200